based on 6 analysts
71.43%
Buy
0.00%
Hold
28.57%
Sell
Based on 6 analysts offering long term price targets for Abbott India Ltd. An average target of ₹27192.17
Source: S&P Global Market Intelligence
Abbott India Ltd price forecast by 6 analysts
Downside of
High
₹32500
Target
₹27192.17
Low
₹17872
Abbott India Ltd target price ₹27192.17, a slight downside of -6.91% compared to current price of ₹29174.6. According to 6 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Abbott India Ltd revenue growth forecast
Expected growth rate Q1, FY2026:0
Forecast
Actual
Including amortisation and stock based compensations
Abbott India Ltd EPS growth forecast
EPS estimate Q1, FY2026:0
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 3.1 % |
3 Month Return | + 4.52 % |
1 Year Return | + 28.59 % |
Market Stats | |
Previous Close | ₹29,209.55 |
Open | ₹29,250.00 |
Volume | 7,010.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹62,070.29Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹62,070.29 Cr |
P/B Ratio | 15.48 |
EPS | 35.67 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 34.88 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹62,070.29 Cr | 34.6% | 0.53 | NA | NA | |
BUY | ₹15,580.03 Cr | 2.14% | 0.52 | ₹602 Cr | ₹2,851 Cr | |
BUY | ₹86,291.18 Cr | 41.72% | 0.56 | ₹3,168 Cr | ₹29,001 Cr | |
HOLD | ₹1,02,882.39 Cr | 63.38% | 0.64 | ₹3,854 Cr | ₹19,547 Cr | |
BUY | ₹45,050.15 Cr | 15.91% | 0.56 | ₹589 Cr | ₹3,453 Cr |
Organisation | Abbott India Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Abbott India Ltd
Abbott India has signed a non-exclusive patent license agreement with Takeda to launch Vonoprazan tablets, enhancing access to gastrointestinal therapy. The company's Q1 FY24 net profit rose 41.1% to Rs 290.24 crore, with revenue increasing by 13.4%. However, shares fell by 0.51% to Rs 27,820.80.
GST Council Meeting May Lower Cancer Drug Prices - 04 Sep, 2024
The upcoming GST council meeting is expected to reduce GST on cancer drugs from 12% to 5%, making treatments more affordable, according to sources.
Abbott India Recalls Pentids Antibiotic Batches - 28 Aug, 2024
Abbott India has initiated a voluntary recall of several batches of its Pentids antibiotic due to complaints of puffing in packaging. The company confirmed no health concerns related to the issue and is collaborating with partners for the recall process.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
Mutual Funds have increased holdings from 7.59% to 7.69% in Sep 2024 quarter
Price Rise
In the last 7 days, ABBOTINDIA stock has moved up by 1.3%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 74.99% of holdings in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 133.4% return, outperforming this stock by 94.3%
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 83.8% return, outperforming this stock by 55.2%
FII Holding Down
Foreign Institutions have decreased holdings from 0.18% to 0.16% in Sep 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 16.02% to 15.85% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 74.99% | 0.00 | |
Foreign Institutions | 0.16% | ||
Mutual Funds | 7.69% | 1.29 | |
Retail Investors | 15.85% | ||
Others | 1.31% | 7.29 |
Abbott India Ltd’s net profit jumped 13.01% since last year same period to ₹328.01Cr in the Q1 2024-2025. On a quarterly growth basis, Abbott India Ltd has generated 14.27% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Abbott India Ltd has declared dividend of ₹410 - translating a dividend yield of 2.52%.
Read More about DividendsBearish
Neutral
Bullish
Abbott India Ltd is currently in a Bullish trading position according to technical analysis indicators.
Abbott India Ltd (ABBOTINDIA) share price today is ₹29174.6
Abbott India Ltd is listed on NSE
Abbott India Ltd is listed on BSE
Today’s traded volume of Abbott India Ltd(ABBOTINDIA) is 7,010.00.
Today’s market capitalisation of Abbott India Ltd(ABBOTINDIA) is ₹62070.29Cr.
Abbott India Ltd(ABBOTINDIA | Price |
---|---|
52 Week High | ₹30521 |
52 Week Low | ₹22000 |
Abbott India Ltd(ABBOTINDIA) share price is ₹29174.6. It is down -4.41% from its 52 Week High price of ₹30521
Abbott India Ltd(ABBOTINDIA) share price is ₹29174.6. It is up 32.61% from its 52 Week Low price of ₹22000
Abbott India Ltd(ABBOTINDIA | Returns |
---|---|
1 Day Returns | -34.95% |
1 Month Returns | 3.1% |
3 Month Returns | 4.52% |
1 Year Returns | 28.59% |